Swiss National Bank Boosts Stake in Qiagen to Over 700,000 Shares

The Swiss National Bank has significantly increased its stake in Qiagen N.V. (NYSE:QGEN), buying an additional 124,920 shares during the first quarter. The bank now owns approximately 716,059 shares of the company's stock, representing a 21.1% increase from the previous period.

This investment is valued at $28,686,000 and accounts for about 0.35% of Qiagen's outstanding shares. The Swiss National Bank's increased position in Qiagen reflects the bank's confidence in the company's prospects.

Qiagen is a global provider of sample and assay technologies, offering solutions for molecular testing in various fields, including molecular diagnostics, applied testing, academic research, and pharmaceutical development.